Terms: = Leukemia AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12
1323 results:
1. Comprehensive analysis of the efficacy and safety of CAR T-cell therapy in patients with relapsed or refractory B-cell acute lymphoblastic leukaemia: a systematic review and meta-analysis.
Willyanto SE; Alimsjah YA; Tanjaya K; Tuekprakhon A; Pawestri AR
Ann Med; 2024 Dec; 56(1):2349796. PubMed ID: 38738799
[TBL] [Abstract] [Full Text] [Related]
2. Frequency and Aberrant CD Marker Profile of Acute Leukaemias.
Arshad MZ; Hassan MA; Bibi M; Hussain M; Alam M; Riaz MO
J Coll Physicians Surg Pak; 2024 May; 34(5):539-544. PubMed ID: 38720213
[TBL] [Abstract] [Full Text] [Related]
3. Unlocking the potential: A novel prognostic index signature for acute myeloid leukemia.
Zhang LQ; Liang YC; Wang JX; Zhang J; La T; Li QZ
Comput Biol Med; 2024 May; 173():108396. PubMed ID: 38574529
[TBL] [Abstract] [Full Text] [Related]
4. Single-cell sequencing unveils T-cell characteristic in acute myeloid leukemia.
Zhu G; Lang W; Fu W; Xu L; Cai J; Zhong H
Int Immunopharmacol; 2024 May; 132():111927. PubMed ID: 38555820
[TBL] [Abstract] [Full Text] [Related]
5. TIM3 and ctla4 immune checkpoint polymorphisms are associated with acute myeloid leukemia in Saudi Arabia.
Alqahtani M; Aljuaimlani A; Al-Tamimi J; Alomar S; Mansour L
Hematology; 2024 Dec; 29(1):2329024. PubMed ID: 38536023
[TBL] [Abstract] [Full Text] [Related]
6. Bispecific antibodies in immunotherapy for adult acute leukemia: latest updates from the 65th American Society of Hematology 2023 Annual Meeting.
Han L; Xing H; Cao W; Song Y; Jiang Z; Yu J
Expert Opin Biol Ther; 2024 Apr; 24(4):221-223. PubMed ID: 38506624
[TBL] [Abstract] [Full Text] [Related]
7. First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.
Narayan R; Piérola AA; Donnellan WB; Yordi AM; Abdul-Hay M; Platzbecker U; Subklewe M; Kadia TM; Alonso-Domínguez JM; McCloskey J; Bradford K; Curtis M; Daskalakis N; Guttke C; Safer K; Hiebert B; Murphy J; Li X; Duchin K; Esteban D
Clin Transl Sci; 2024 Mar; 17(3):e13742. PubMed ID: 38494922
[TBL] [Abstract] [Full Text] [Related]
8. STING-activating cyclic dinucleotide-manganese nanoparticles evoke robust immunity against acute myeloid leukemia.
Aikins ME; Sun X; Dobson H; Zhou X; Xu Y; Lei YL; Moon JJ
J Control Release; 2024 Apr; 368():768-779. PubMed ID: 38492861
[TBL] [Abstract] [Full Text] [Related]
9. Cancer stem cells: The important role of CD markers, Signaling pathways, and MicroRNAs.
Gholamzad A; Khakpour N; Khosroshahi EM; Asadi S; Koohpar ZK; Matinahmadi A; Jebali A; Rashidi M; Hashemi M; Sadi FH; Gholamzad M
Pathol Res Pract; 2024 Apr; 256():155227. PubMed ID: 38490099
[TBL] [Abstract] [Full Text] [Related]
10. Simultaneous Purification of Human Interferon Alpha-2b and Serum Albumin Using Bioprivileged Fluorinated Ionic Liquid-Based Aqueous Biphasic Systems.
Carvalho SF; Pereiro AB; Araújo JMM
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473998
[TBL] [Abstract] [Full Text] [Related]
11. 5-methylcytosine RNA modification regulators-based patterns and features of immune microenvironment in acute myeloid leukemia.
Ding Y; Bajpai AK; Wu F; Lu W; Xu L; Mao J; Li Q; Pan Q; Lu L; Wang X
Aging (Albany NY); 2024 Jan; 16(3):2340-2361. PubMed ID: 38277218
[TBL] [Abstract] [Full Text] [Related]
12.
Battaglin F; Baca Y; Millstein J; Yang Y; Xiu J; Arai H; Wang J; Ou FS; Innocenti F; Mumenthaler SM; Jayachandran P; Kawanishi N; Lenz A; Soni S; Algaze S; Zhang W; Khoukaz T; Roussos Torres E; Seeber A; Abraham JP; Lou E; Philip PA; Weinberg BA; Shields AF; Goldberg RM; Marshall JL; Venook AP; Korn WM; Lenz HJ
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38212126
[TBL] [Abstract] [Full Text] [Related]
13. CD8 + T cell-based molecular subtypes with heterogeneous immune landscapes and clinical significance in acute myeloid leukemia.
Zhong F; Yao F; Jiang J; Yu X; Liu J; Huang B; Wang X
Inflamm Res; 2024 Mar; 73(3):329-344. PubMed ID: 38195768
[TBL] [Abstract] [Full Text] [Related]
14. Maintenance therapy for chronic lymphocytic leukaemia.
Lee CH; Wu YY; Huang TC; Lin C; Zou YF; Cheng JC; Chen PH; Jhou HJ; Ho CL
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD013474. PubMed ID: 38174814
[TBL] [Abstract] [Full Text] [Related]
15. System analysis of surface CD markers during the process of granulocytic differentiation.
Novikova SE; Tolstova TV; Soloveva NA; Farafonova TE; Tikhonova OV; Kurbatov LK; Rusanov AL; Zgoda VG
Biomed Khim; 2023 Dec; 69(6):383-393. PubMed ID: 38153053
[TBL] [Abstract] [Full Text] [Related]
16. TIGIT is Frequently Expressed in the Tumor Microenvironment of Select Lymphomas: Implications for Targeted Therapy.
Libert D; Zhao S; Younes S; Mosquera AP; Bharadwaj S; Ferreira C; Natkunam Y
Am J Surg Pathol; 2024 Mar; 48(3):337-352. PubMed ID: 38148663
[TBL] [Abstract] [Full Text] [Related]
17. Granulocyte-Macrophage-Colony-Stimulating-Factor Combined with Prostaglandin E1 Create Dendritic Cells of Leukemic Origin from AML Patients' Whole Blood and Whole Bone Marrow That Mediate Antileukemic Processes after Mixed Lymphocyte Culture.
Unterfrauner M; Rejeski HA; Hartz A; Bohlscheid S; Baudrexler T; Feng X; Rackl E; Li L; Rank A; Filippini Velázquez G; Schmid C; Schmohl J; Bojko P; Schmetzer H
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139264
[TBL] [Abstract] [Full Text] [Related]
18. Resistance to apoptosis in complicated Crohn's disease: Relevance in ileal fibrosis.
Seco-Cervera M; Ortiz-Masiá D; Macias-Ceja DC; Coll S; Gisbert-Ferrándiz L; Cosín-Roger J; Bauset C; Ortega M; Heras-Morán B; Navarro-Vicente F; Millán M; Esplugues JV; Calatayud S; Barrachina MD
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166966. PubMed ID: 37995775
[TBL] [Abstract] [Full Text] [Related]
19. The diagnostic/prognostic roles and biological function of the IFIT family members in acute myeloid leukemia.
Zhao Y; Zhang Y; Lu W; Sun R; Guo R; Cao X; Liu X; Lyu C; Zhao M
BMC Med Genomics; 2023 Nov; 16(1):296. PubMed ID: 37980495
[TBL] [Abstract] [Full Text] [Related]
20. A pan-cancer analysis of the MAPK family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Qin YY; Yang Y; Ren YH; Gao F; Wang MJ; Li G; Liu YX; Fan L
Medicine (Baltimore); 2023 Nov; 102(45):e35829. PubMed ID: 37960824
[TBL] [Abstract] [Full Text] [Related]
[Next]
